Botulinum toxin type a (BOTOX) for treatment of migraine headaches: An open-label study

Otolaryngology - Head and Neck Surgery

Volumn 123, Issue 6, 2000, Pages 669-676

  Binder, William J ^a   Brin, Mitchell F ^b   Blitzer, Andrew ^c   Schoenrock, Larry D ^d   Pogoda, Janice M ^e,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Mt Sinai Medical Center   (United States)

^c Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DYSTONIA; FEMALE; FOREHEAD; HEAD; HUMAN; INJECTION SITE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; PROPHYLAXIS; TREATMENT OUTCOME;

EID: 0033668492     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhn.2000.110960     Document Type: Article

References (24)

1. Migraine. Patterns of healthcare use
2. The management of hyperfunctional facial lines with botulinum toxin: A collaborative study of 210 injection sites in 162 patients
3. Treatment of hyperfunctional lines of the face with botulinum toxin A
4. The origin, structure, and pharmacological activity of botulinum toxin
5. Commentary: The synaptic vesicle and its targets
6. Migraine classification and diagnosis. International Headache Society criteria
7. Pathophysiology of migraine and tension-type headache
8. Correlation between essential tremor and migraine headache
9. Genetic heterogeneity of familial hemiplegic migraine
10. The neurobiology of vascular head pain
11. High-frequency stimulation of the facial nerve results in local cortical release of vasoactive intestinal polypeptide in the anesthetised cat
12. Extracranial vasodilation mediated by vasoactive intestinal polypeptide (VIP)
13. The clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs
14. Sumatriptan
15. Botullnum toxin: New and expanded indications
16. Treatment of dystonia
17. Psychophysiology of recurrent headache: Methodological issues and new empirical findings
18. Rhinorrhea is decreased in dogs after nasal application of botulinum toxin
19. Selective location of acceptors for botulinum neurotoxin A in the central and peripheral nervous systems
20. Molecular action of botulinum neurotoxins: Role of acceptors in targetting to cholinergic nerves and in the inhibition of the release of several transmitters
21. Botulinum: A neurotoxin for axillary hyperhidrosis
22. NeuropeptideY coexists with vasoactive intestinal polypeptide and acetylcholine in parasympathetic cerebrovascular nerves originating in the sphenopalatine, otic and internal carotid ganglia of the rat
23. Calcitonin gene-related peptide: Possible role in formation and maintenance of neuromuscular junctions